| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 10.02.
| St Jude Medical Bearish Moving Average Crossover Alert | | 1 | SmarTrend |
| 06.02.
| UBS hebt das Kursziel für St Jude Medical von $42 auf $48. | | 39 | BörseGo |
| UBS hebt das Kursziel für St Jude Medical von $42 auf $48.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
UBS hebt das Kursziel für St Jude Medical von $42 auf $48. | |
| 03.02.
| The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | | 89 | PR Newswire |
| CHICAGO, Feb. 3, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and Southwest Airlines | |
| 02.02.
| St. Jude Medical Advances its Remote Patient Monitoring System in the UK with Mobile Notifications | | 54 | Business Wire |
| New features in telehealth system allow for easier physician response
and follow-up
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company...
Mehr lesen zu:
St. Jude Medical Advances its Remote Patient Monitoring System in the UK with Mobile Notifications | |
| 31.01.
| St Jude Medical Approaches New Upside Target of $42.08 | | - | SmarTrend |
| 31.01.
| St Jude Medical Up 17.6% Since SmarTrend Uptrend Call | | - | SmarTrend |
| 26.01.
| The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and CA | | 52 | PR Newswire |
| CHICAGO, Jan. 26, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
Mehr lesen zu:
The Zacks Analyst Blog Highlights: Medtronic, Edwards Lifesciences, Boston Scientific, St Jude Medical and CA | |
| 26.01.
| Zacks Bull and Bear of the Day Highlights: Caterpillar, NII Holdings, Lowe's Companies, Home Depot and St. Jude Medical | | 27 | PR Newswire |
| CHICAGO, Jan. 24, 2012 /PRNewswire/ -- Zacks Equity Research highlights Caterpillar, Inc. (NYSE: CAT) as the Bull of the Day and NII Holdings, Inc. (Nasdaq: NIHD) as the Bear of the Day. In addition...
Mehr lesen zu:
Zacks Bull and Bear of the Day Highlights: Caterpillar, NII Holdings, Lowe's Companies, Home Depot and St. Jude Medical | |
| 25.01.
| St. Jude Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript | | 4 | Seeking Alpha |
| 25.01.
| St. Jude Medical Beats Up on Analysts Yet Again | | 2 | Motley Fool |
| 25.01.
| St. Jude Profit Declines On Charges, But Tops Estimate | | 51 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical Inc. (STJ) said Wednesday its
fourth-quarter profit declined from a year ago as one-time impairments offset a
four percent growth in sales. Nevertheless...
Mehr lesen zu:
St. Jude Profit Declines On Charges, But Tops Estimate | |
| 25.01.
| St. Jude Medical posts lower profit | | 4 | MarketWatch |
| 25.01.
| St. Jude Medical Q4 Profit Drops, Guides Q1, 2012 | | 15 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical Inc. (STJ) Wednesday said net
earnings for the fourth quarter were $163 million, or $0.51 per share. This
compares to reported net earnings for 2010...
Mehr lesen zu:
St. Jude Medical Q4 Profit Drops, Guides Q1, 2012 | |
| 25.01.
| St. Jude Medical Reports Fourth Quarter and Full-Year 2011 Results | | 27 | Business Wire |
| St. Jude Medical, Inc. (NYSE: STJ) today reported sales and net earnings
for the fourth quarter and year ended December 31, 2011.
Fourth Quarter and Full-Year...
Mehr lesen zu:
St. Jude Medical Reports Fourth Quarter and Full-Year 2011 Results | |
| 25.01.
| St. Jude Medical: Earnings Preview | | - | Seeking Alpha |
| 19.01.
| St Jude Medical Set to Possibly Pullback After Yesterday's Rally of 2.50% | | 2 | SmarTrend |
| 19.01.
| Upgrade Alert for St Jude Medical | | 3 | SmarTrend |
| 18.01.
| Unabhängiges Kontrollgremium für Datensicherheit empfiehlt nach positiver Zwischenanalyse einen Stopp der Patientenaufnahme für klinische FAME II-Studie von St. Jude Medical | | 48 | Business Wire |
| Folgestudie der richtungsweisenden FAME-Studie untersucht Vorteile von
FFR-gestützten Beurteilungen in Kombination mit optimaler medizinischer
Therapie bei Stent-Implantationen...
Mehr lesen zu:
Unabhängiges Kontrollgremium für Datensicherheit empfiehlt nach positiver Zwischenanalyse einen Stopp der Patientenaufnahme für klinische FAME II-Studie von St. Jude Medical | |
| 18.01.
| Has St. Jude Medical Become the Perfect Stock? | | 1 | Motley Fool |
| 18.01.
| DSMB Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment | | 37 | AFX News |
| WASHINGTON (dpa-AFX) - St. Jude Medical Inc. (STJ) announced that an interim
analysis of the FAME II trial has found a highly statistically significant
reduction in the need for hospital...
Mehr lesen zu:
DSMB Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment | |
